Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions , ) decreases the risk of skin cancer and early skin aging caused by the sun.
Origins
- Manufacturer
- ORIGINS NATURAL RESOURCES INC. | ELGC Kabushiki Kaisha | Estee Lauder Pennsylvania Distribution Center 2 (PADC 2) | ARAMIS, INC | ESTEE LAUDER COSMETICS DISTRIBUTION CENTER | ESTEE LAUDER COSMETICS, LTD | ESTEE LAUDER COSMETICS, LTD. | ESTEE LAUDER N.V. | LEN-RON MANUFACTURING DIVISION OF ARAMIS INC | NORTEC KEYSTONE | NORTHTEC BRISTOL | NORTHTEC KEYSTONE | WHITMAN LABORATORIES, LTD. | Aveda Corporation
- Effective date
- 2012-02-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:03
Label at a glance#
ProductOrigins A PERFECT WORLD AGE DEFENSE TINTED MOISTURIZER SPF 15
Active ingredientoctinoxate, octisalate, avobenzone
Label structure9 sections
Dosage and administration
For sunscreen use: apply generously and evenly 15 minutes before sun exposure reapply at least every two hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum value of 15 or higher and other sun protection measures including: limit...
Storage and handling
protect the product in this container from excessive heat and direct sun
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| octinoxate 7.50% | Sunscreen |
| octisalate 5.00% | Sunscreen |
| avobenzone 2.00% | Sunscreen |
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions,) decreases the risk of skin cancer and early skin aging caused by the sun.
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
For sunscreen use:
- apply generously and evenly 15 minutes before sun exposure
- reapply at least every two hours
- use a water resistant sunscreen if swimming or sweating
- Sun Protection Measures.
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum value of 15 or higher and other sun protection measures including:- limit time in the sun, especially from 10am – 2pm
- wear long-sleeved shirts, pants, hats and sunglasses
- children under 6 months of age: ask a doctor
Inactive ingredients
water • dimethicone • caprylic/capric/myristic/stearic triglyceride • butylene glycol • cyclopentasiloxane • steareth-2 • cetyl ricinoleate • di-c12-15 alkyl fumarate • polysilicone-11 • pentylene glycol • steareth-21 • coffea arabica (coffee) seed extract • triticum vulgare (wheat) germ extract • laminaria ochroleuca extract • hordeum vulgare (barley) extract\extrait d'orge • camellia sinensis (white tea) leaf extract • polyethylene • hydrogenated lecithin • stearyl alcohol • polyaminopropyl biguanide • linoleic acid • cholesterol • dimethicone copolyol • squalane • caffeine • sodium pca • urea • caprylic/capric triglyceride • hexylene glycol • sodium hyaluronate • pantethine • polyquaternium-51 • sodium hydroxide • trehalose • oryzanol • ascorbyl tocopheryl maleate • tromethamine • glycerin • peg-9 dimethicone • behenyl alcohol • pvp/hexadecene copolymer • carbomer • caprylyl glycol • fragrance • disodium edta • linalool • limonene • citral • sorbic acid • phenoxyethanol • potassium sorbate • chlorphenesin • [+/- titanium dioxide (ci 77891) • iron oxides (ci 77491, ci 77492, ci 77499) • bismuth oxychloride (ci 77163) • ferric ammonium ferrocyanide (ci 77510) • mica • red 7 lake (ci 15850)] <iln38491>
Other information
- protect the product in this container from excessive heat and direct sun
SPL UNCLASSIFIED SECTION
©Origins Nat. Res., Dist. New York, NY 10022
PRINCIPAL DISPLAY PANEL - 50 ml Bottle Carton
ORIGINS
A Perfect World™
SPF 15
Age-defense
tinted moisturizer
with White Tea
Broad Spectrum SPF 15
1.7 fl. oz./50 ml e
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59427-001-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1ae8-f424-e053-dadaa90a57ce | ORIGINS A PERFECT WORLD™ AGE DEFENSE TINTED MOISTURIZER SPF 15 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59427-001-01 | Origins A PERFECT WORLD AGE DEFENSE TINTED MOISTURIZER SPF 15 | 50 mL in 1 BOTTLE | LIQUID | 50 | 1 | |
| 59427-001-01 | Origins A PERFECT WORLD AGE DEFENSE TINTED MOISTURIZER SPF 15 | 1 in 1 CARTON | LIQUID | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59427-001 | ORIGINS A PERFECT WORLD AGE DEFENSE TINTED MOISTURIZER SPF 15 (OCTINOXATE, OCTISALATE, AND AVOBENZONE) LIQUID [ORIGINS NATURAL RESOURCES INC.] | 1 | Legacy NDC, 2 package rows | 20120302_9f78ab71-980b-48cf-b9d1-92175f888b73.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| arabica coffee bean | INACTIVE INGREDIENT | 3SW678MX72 | 1 | |
| bismuth oxychloride | INACTIVE INGREDIENT | 4ZR792I587 | 1 | |
| butylene glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| caffeine | INACTIVE INGREDIENT | 3G6A5W338E | 1 | |
| caprylyl glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| cetyl ricinoleate | INACTIVE INGREDIENT | 1P677500YD | 1 | |
| chlorphenesin | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| cholesterol | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| citral | INACTIVE INGREDIENT | T7EU0O9VPP | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| di-c12-15 alkyl fumarate | INACTIVE INGREDIENT | A1CB3Z898P | 1 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 1 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| ferric ammonium ferrocyanide | INACTIVE INGREDIENT | 9R0NVI936I | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| gamma oryzanol | INACTIVE INGREDIENT | SST9XCL51M | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| hexylene glycol | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| high density polyethylene | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| hyaluronate sodium | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| laminaria ochroleuca | INACTIVE INGREDIENT | 4R2124HE76 | 1 | |
| linalool, (+/-)- | INACTIVE INGREDIENT | D81QY6I88E | 1 | |
| linoleic acid | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| medium-chain triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| pantethine | INACTIVE INGREDIENT | 7K81IL792L | 1 | |
| pentylene glycol | INACTIVE INGREDIENT | 50C1307PZG | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| polyaminopropyl biguanide | INACTIVE INGREDIENT | 322U039GMF | 1 | |
| potassium sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| sodium pyrrolidone carboxylate | INACTIVE INGREDIENT | 469OTG57A2 | 1 | |
| sorbic acid | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| steareth-2 | INACTIVE INGREDIENT | V56DFE46J5 | 1 | |
| steareth-21 | INACTIVE INGREDIENT | 53J3F32P58 | 1 | |
| stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| trehalose | INACTIVE INGREDIENT | B8WCK70T7I | 1 | |
| tromethamine | INACTIVE INGREDIENT | 023C2WHX2V | 1 | |
| urea | INACTIVE INGREDIENT | 8W8T17847W | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| wheat germ | INACTIVE INGREDIENT | YR3G369F5A | 1 |
Products#
Every source-derived product name is available through these pages.
- Origins A PERFECT WORLD AGE DEFENSE TINTED MOISTURIZER SPF 15
- octinoxate, octisalate, and avobenzone
- octinoxate
- octisalate
- avobenzone
- water
- dimethicone
- butylene glycol
- cyclomethicone 5
- steareth-2
- cetyl ricinoleate
- di-c12-15 alkyl fumarate
- pentylene glycol
- steareth-21
- arabica coffee bean
- wheat germ
- laminaria ochroleuca
- high density polyethylene
- stearyl alcohol
- polyaminopropyl biguanide
- linoleic acid
- cholesterol
- squalane
- caffeine
- sodium pyrrolidone carboxylate
- urea
- medium-chain triglycerides
- hexylene glycol
- hyaluronate sodium
- pantethine
- sodium hydroxide
- trehalose
- gamma oryzanol
- tromethamine
- glycerin
- docosanol
- caprylyl glycol
- edetate disodium
- linalool, (+/-)-
- citral
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 59427-001 | 59427-001-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| steareth-21 | STEARETH-21 | 53J3F32P58 | CREAM / TOPICAL | 3 %w/w | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET, CHEWABLE / ORAL | NA | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CREAM, AUGMENTED / TOPICAL | 6 mg | ||
| squalane | SQUALANE | GW89575KF9 | CREAM / TOPICAL | 6 %w/w | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / DENTAL | ADJ PH | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTERIAL | 176 mg | ||
| cholesterol | CHOLESTEROL | 97C5T2UQ7J | INJECTABLE, LIPOSOMAL / INFILTRATION | 0.47 %w/v | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | ADJ PH | ||
| tromethamine | TROMETHAMINE | 023C2WHX2V | SOLUTION / INTRAVASCULAR | 0.12 %w/v | ||
| hyaluronate sodium | HYALURONATE SODIUM | YSE9PPT4TH | GEL / TOPICAL | 463 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CAPSULE, EXTENDED RELEASE / ORAL | 4.53 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, EXTENDED RELEASE / ORAL | 7 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| butylene glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| tromethamine | TROMETHAMINE | 023C2WHX2V | GEL / TOPICAL | 56 mg | ||
| tromethamine | TROMETHAMINE | 023C2WHX2V | SUSPENSION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / ENDOTRACHEAL | ADJ PH | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | PASTE / DENTAL | 60 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / PARENTERAL | ADJ PH | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL / OPHTHALMIC | 6 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAMUSCULAR | ADJ PH | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| tromethamine | TROMETHAMINE | 023C2WHX2V | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET, COATED / ORAL | 1 mg | ||
| ferrosoferric oxide | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, EXTENDED RELEASE / ORAL | 1.49 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBARACHNOID | ADJ PH | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| cholesterol | CHOLESTEROL | 97C5T2UQ7J | INJECTION / INTRAVENOUS | 93 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SUPPOSITORY / RECTAL | NA | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRASYNOVIAL | ADJ PH | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, COATED / ORAL | 1 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | TABLET, EXTENDED RELEASE / ORAL | 13 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / TOPICAL | ADJ PH | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| tromethamine | TROMETHAMINE | 023C2WHX2V | INJECTION, SOLUTION / INTRAVENOUS | 300 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| hyaluronate sodium | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAVENOUS | 2.78 %w/v | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | TABLET / ORAL | 10 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 13d96107-e053-472d-aeaf-98cd1e2773ef | 9f78ab71-980b-48cf-b9d1-92175f888b73 | 2012-02-13 | Warnings | 13d96107-e053-472d-aeaf-98cd1e2773ef 9f78ab71-980b-48cf-b9d1-92175f888b73 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.